SI
ELV icon

Seeds Investor’s Elevance Health ELV Stock Holding History

Seeds Investor’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-758
Closed -$266K – 357
2025
Q4 		$266K Buy
+758
New +$256K 0.05% 217
2025
Q3 		– Sell
-680
Closed -$264K – 256
2025
Q2 		$264K Sell
680
-269
-28% -$108K 0.06% 195
2025
Q1 		$413K Sell
949
-181
-16% -$72.7K 0.12% 128
2024
Q4 		$417K Sell
1,130
-842
-43% -$352K 0.12% 124
2024
Q3 		$1.03M Sell
1,972
-67
-3% -$35.8K 0.38% 42
2024
Q2 		$1.1M Buy
2,039
+141
+7% +$74.5K 0.57% 29
2024
Q1 		$984K Buy
1,898
+85
+5% +$42.3K 0.91% 18
2023
Q4 		$855K Buy
+1,813
New +$838K 0.97% 23

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Seeds Investor's ELV Position: Q1 2026 in Review

Seeds Investor sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 758 shares — an estimated $266K sold.

Seeds Investor first reported a position in ELV in Q4 2023 and held it in 8 quarters. The position peaked at $1.1M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Seeds Investor reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Seeds Investor sold 758 Elevance Health shares in Q1 2026, an estimated $266K.
  • Seeds Investor first reported a position in Elevance Health in Q4 2023 and held it in 8 quarters.
  • Seeds Investor's Elevance Health position peaked at $1.1M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Seeds Investor's 13F filing for Q1 2026, filed 11 May 2026.